ResearcherMassachusetts Institute of TechnologyNo recent work listed
Allison N. Lau
Matched on ORCID iD 0000-0003-4250-7355; OpenAlex author ID A5057349628; NIH RePORTER profile ID 9676782. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 28
2018: 2 papers · 2019: 1 paper · 2020: 1 paper, 1 grant · 2021: 1 paper
Papers 5
- Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells. Co-author DOI 10.1038/s41467-021-22490-9↗
- Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. Co-author DOI 10.7554/elife.56782↗
- Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance. Co-author DOI 10.1158/0008-5472.can-19-0960↗
- Altered exocrine function can drive adipose wasting in early pancreatic cancer. Co-author DOI 10.1038/s41586-018-0235-7↗
- PKM2 is not required for pancreatic ductal adenocarcinoma. First author DOI 10.1186/s40170-018-0188-1↗
Grants 1
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew G. Vander Heiden · 5 shared papers, 2018–2021 · strength 0.46
- Paper Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tu… DOI 10.1038/s41467-021-22490-9↗
- Paper PKM2 is not required for pancreatic ductal adenocarcinoma. DOI 10.1186/s40170-018-0188-1↗
- Paper Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. DOI 10.7554/elife.56782↗
- Laura V. Danai · 3 shared papers, 2018–2020 · strength 0.23
- Paper PKM2 is not required for pancreatic ductal adenocarcinoma. DOI 10.1186/s40170-018-0188-1↗
- Paper Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. DOI 10.7554/elife.56782↗
- Paper Altered exocrine function can drive adipose wasting in early pancreatic cancer. DOI 10.1038/s41586-018-0235-7↗
- Evan Chen Lien · 2 shared papers, 2018–2020 · strength 0.14
- Jared R. Mayers · 2 shared papers, 2018–2020 · strength 0.14
- Steven A. Carr · 1 shared paper, 2021 · strength 0.14
- Richard O. Hynes · 1 shared paper, 2021 · strength 0.14
- Chenxi Tian · 1 shared paper, 2021 · strength 0.14
- Alissandra L. Hillis · 1 shared paper, 2018 · strength 0.09
- David Arthur Tuveson · 1 shared paper, 2020 · strength 0.09
- Giulia Biffi · 1 shared paper, 2020 · strength 0.09
- Tyler Jacks · 1 shared paper, 2020 · strength 0.09
- Simona Dalin · 1 shared paper, 2019 · strength 0.09
- Michael T. Hemann · 1 shared paper, 2019 · strength 0.09
- Ana Babić · 1 shared paper, 2018 · strength 0.06
- Albert C. Koong · 1 shared paper, 2018 · strength 0.06
- Chen Yuan · 1 shared paper, 2018 · strength 0.06
- Michael Hayden Rosenthal · 1 shared paper, 2018 · strength 0.06
- Alexander Muir · 1 shared paper, 2018 · strength 0.06
- Carlos F. Fernandez-del Castillo · 1 shared paper, 2018 · strength 0.06
- Motokazu Sugimoto · 1 shared paper, 2018 · strength 0.06
- Nicole Lopez · 1 shared paper, 2018 · strength 0.06
- Naoki Takahashi · 1 shared paper, 2018 · strength 0.06
- Jen Jen Yeh · 1 shared paper, 2018 · strength 0.06
- Brian Matthew Wolpin · 1 shared paper, 2018 · strength 0.06
- Andrew Scott Liss · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.